JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306889200 on September 12, 2003

J. Biol. Chem., Vol. 278, Issue 48, 48120-48128, November 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/48/48120    most recent
M306889200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pawlyk, A. C.
Right arrow Articles by Lee, V. M.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pawlyk, A. C.
Right arrow Articles by Lee, V. M.-Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age*

Aaron C. Pawlyk{ddagger}§, Benoit I. Giasson{ddagger}§||, Deepak M. Sampathu{ddagger}, Francisco A. Perez**, Kah Leong Lim{ddagger}{ddagger}, Valina L. Dawson§§, Ted M. Dawson§§, Richard D. Palmiter**, John Q. Trojanowski{ddagger}¶¶, and Virginia M.-Y. Lee{ddagger}||||

From the {ddagger}Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, and ¶¶Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, the **Department of Biochemistry, University of Washington, Seattle, Washington 98195, {ddagger}{ddagger}Neurodegeneration Research Laboratory, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore, and the §§Departments of Neurology and Neuroscience, The Johns Hopkins University, Baltimore, Maryland 21287

Autosomal recessive juvenile parkinsonism is a movement disorder associated with the degeneration of dopaminergic neurons in substantia nigra pars compacta. The loss of functional parkin caused by parkin gene mutations is the most common single cause of juvenile parkinsonism. Parkin has been shown to aid in protecting cells from endoplasmic reticulum and oxidative stressors presumably due to ubiquitin ligase activity of parkin that targets proteins for proteasomal degradation. However, studies on parkin have been impeded because of limited reagents specific for this protein. Here we report the generation and characterization of a panel of parkin-specific monoclonal antibodies. Biochemical analyses indicate that parkin is present only in the high salt-extractable fraction of mouse brain, whereas it is present in both the high salt-extractable and RIPA-resistant, SDS-extractable fraction in young human brain. Parkin is present at decreased levels in the high salt-extractable fraction and at increased levels in the SDS-extractable fraction from aged human brain. This shift in the extractability of parkin upon aging is seen in humans but not in mice, demonstrating species-specific differences in the biochemical characteristics of murine versus human parkin. Finally, by using these highly specific anti-parkin monoclonal antibodies, it was not possible to detect parkin in {alpha}-synuclein-containing lesions in {alpha}-synucleinopathies, thereby challenging prior inferences about the role of parkin in movement disorders other than autosomal recessive juvenile parkinsonism.


Received for publication, June 27, 2003 , and in revised form, September 3, 2003.

* This work was supported in part by NIA and NINDS grants from the National Institutes of Health and the Michael J. Fox Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

Supported by a National Institutes of Health training grant (Training in Age-related Neurodegenerative Diseases).

|| Supported by a fellowship from the Canadian Institutes of Health Research.

|||| The John H. Ware III Chair of Alzheimer's Research. To whom correspondence should be addressed. Tel.: 215-662-6427; E-mail: vmylee{at}mail.med.upenn.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Biol.Home page
J. A. Olzmann, L. Li, M. V. Chudaev, J. Chen, F. A. Perez, R. D. Palmiter, and L.-S. Chin
Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6
J. Cell Biol., September 7, 2007; 178(6): 1025 - 1038.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al.
Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling
J. Neurosci., February 21, 2007; 27(8): 1868 - 1878.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T.-K. Sang, H.-Y. Chang, G. M. Lawless, A. Ratnaparkhi, L. Mee, L. C. Ackerson, N. T. Maidment, D. E. Krantz, and G. R. Jackson
A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine
J. Neurosci., January 31, 2007; 27(5): 981 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al.
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
J. Neurosci., April 5, 2006; 26(14): 3685 - 3696.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Uryu, C. Richter-Landsberg, W. Welch, E. Sun, O. Goldbaum, E. H. Norris, C.-T. Pham, I. Yazawa, K. Hilburger, M. Micsenyi, et al.
Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies
Am. J. Pathol., March 1, 2006; 168(3): 947 - 961.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Matsuda, T. Kitami, T. Suzuki, Y. Mizuno, N. Hattori, and K. Tanaka
Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro
J. Biol. Chem., February 10, 2006; 281(6): 3204 - 3209.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al.
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function
Hum. Mol. Genet., December 15, 2005; 14(24): 3885 - 3897.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Zhang, M. Shimoji, B. Thomas, D. J. Moore, S.-W. Yu, N. I. Marupudi, R. Torp, I. A. Torgner, O. P. Ottersen, T. M. Dawson, et al.
Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis
Hum. Mol. Genet., July 15, 2005; 14(14): 2063 - 2073.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease
PNAS, May 31, 2005; 102(22): 8024 - 8029.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. C. Greene, A. J. Whitworth, L. A. Andrews, T. J. Parker, and L. J. Pallanck
Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis
Hum. Mol. Genet., March 15, 2005; 14(6): 799 - 811.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. Perez and R. D. Palmiter
Parkin-deficient mice are not a robust model of parkinsonism
PNAS, February 8, 2005; 102(6): 2174 - 2179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass
Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity
J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. J. Moore, L. Zhang, J. Troncoso, M. K. Lee, N. Hattori, Y. Mizuno, T. M. Dawson, and V. L. Dawson
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress
Hum. Mol. Genet., January 1, 2005; 14(1): 71 - 84.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. von Coelln, B. Thomas, J. M. Savitt, K. L. Lim, M. Sasaki, E. J. Hess, V. L. Dawson, and T. M. Dawson
Loss of locus coeruleus neurons and reduced startle in parkin null mice
PNAS, July 20, 2004; 101(29): 10744 - 10749.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.